Contact
searchSearch
HMP Global

Medication Safety

Featured Article

Poll
Pharmacy Benefit Managers vs Independent Pharmacies
03/25/2024
03/25/2024
Pharmacy Learning Network
Quiz
Reviewing the Stop Dangerous Pharmacies Act
03/07/2024
What is the Stop Dangerous Pharmacies Act?
What is the Stop Dangerous Pharmacies Act?
What is the Stop Dangerous...
03/07/2024
Pharmacy Learning Network
News
Global GLP-1 Agonist Market Trends
03/04/2024

Emry Lloyd

Emry Lloyd
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report...
03/04/2024
Pharmacy Learning Network
Poll
Ensuring Safe and Effective Use of Weight Loss Drugs
03/01/2024
03/01/2024
Pharmacy Learning Network
News
Subpotent Eye Solution Recalled
09/21/2023
Jolynn Tumolo
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries...
09/21/2023
Pharmacy Learning Network
News
Homeopathic Products Pulled
07/07/2023
Jolynn Tumolo
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products...
07/07/2023
Pharmacy Learning Network
News
Opioid Analgesic Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Antifungal Injection Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Label/Capsule Mix-Up Prompts Recall
06/30/2023
Jolynn Tumolo
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to...
06/30/2023
Pharmacy Learning Network
News
Class I Recall for Contaminated Hand Sanitizers
06/23/2023
Jolynn Tumolo
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued...
06/23/2023
Pharmacy Learning Network
News
Anticonvulsant Capsules Recalled
06/23/2023
Jolynn Tumolo
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been...
06/23/2023
Pharmacy Learning Network

Newsfeed

News
Global GLP-1 Agonist Market Trends
03/04/2024

Emry Lloyd

Emry Lloyd
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report...
03/04/2024
Pharmacy Learning Network
News
Subpotent Eye Solution Recalled
09/21/2023
Jolynn Tumolo
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries...
09/21/2023
Pharmacy Learning Network
News
Homeopathic Products Pulled
07/07/2023
Jolynn Tumolo
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products...
07/07/2023
Pharmacy Learning Network
News
Opioid Analgesic Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Antifungal Injection Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Label/Capsule Mix-Up Prompts Recall
06/30/2023
Jolynn Tumolo
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to...
06/30/2023
Pharmacy Learning Network
News
Class I Recall for Contaminated Hand Sanitizers
06/23/2023
Jolynn Tumolo
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued...
06/23/2023
Pharmacy Learning Network
News
Anticonvulsant Capsules Recalled
06/23/2023
Jolynn Tumolo
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been...
06/23/2023
Pharmacy Learning Network
News
Antifibrinolytic Drug Recalled
06/23/2023
Jolynn Tumolo
A recall has been issued by two firms for antifibrinolytic drug tablets, distributed throughout the United States, for failing to meet impurity/degradation specifications.
A recall has been issued by two firms for antifibrinolytic drug tablets, distributed throughout the United States, for failing to meet impurity/degradation specifications.
A recall has been issued by two...
06/23/2023
Pharmacy Learning Network
News
Injection Recalled After Manufacturer Halts Quality Program
06/16/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injection anticholinergic/antispasmodic drug due to the manufacturer discontinuing their quality assurance program.
A Class II recall has been issued for a prescription injection anticholinergic/antispasmodic drug due to the manufacturer discontinuing their quality assurance program.
A Class II recall has been...
06/16/2023
Pharmacy Learning Network
News
BioSpectra Tris/Tromethamine Recalled Due to Failed Stability Specifications
10/15/2026
Rebecca Amrick
BioSpectra voluntarily recalled 200 kg of tris/tromethamine after the product failed to meet stability specifications, prompting a Class II classification by the FDA.
BioSpectra voluntarily recalled 200 kg of tris/tromethamine after the product failed to meet stability specifications, prompting a Class II classification by the FDA.
BioSpectra voluntarily recalled...
10/15/2026
Pharmacy Learning Network
News
Fosfomycin Tromethamine Recalled Due to Failed Impurities Specifications
10/15/2026
Rebecca Amrick
A voluntary Class II recall has been issued for fosfomycin tromethamine granules for oral solution due to the product’s failure to meet impurities specifications.
A voluntary Class II recall has been issued for fosfomycin tromethamine granules for oral solution due to the product’s failure to meet impurities specifications.
A voluntary Class II recall has...
10/15/2026
Pharmacy Learning Network
News
IMAAVY Injection Recalled Due to the Presence of Particulate Matter
10/15/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for IMAAVY (nipocalimab-aahu) injection due to the presence of particulate matter, affecting 49 vials.
The US Food and Drug Administration (FDA) has issued a Class II recall for IMAAVY (nipocalimab-aahu) injection due to the presence of particulate matter, affecting 49 vials.
The US Food and Drug...
10/15/2026
Pharmacy Learning Network
PharmLaw
CVS $315 Million Settlement Highlights Controlled Substance Dispensing and Pharmacy Compliance Obligations
10/14/2026
Hannah Musick
CVS has agreed to pay $315 million to resolve federal allegations of unlawful controlled substance dispensing and improper Medicare billing, underscoring ongoing enforcement of pharmacy compliance requirements under the Controlled Substances...
CVS has agreed to pay $315 million to resolve federal allegations of unlawful controlled substance dispensing and improper Medicare billing, underscoring ongoing enforcement of pharmacy compliance requirements under the Controlled Substances...
CVS has agreed to pay $315...
10/14/2026
Pharmacy Learning Network
News
Estradiol Gel Recalled Due to Defective Container
10/08/2026
Rebecca Amrick
Estradiol gel is under a voluntary Class II recall after defects were discovered in the product’s container, affecting 2592 cartons.
Estradiol gel is under a voluntary Class II recall after defects were discovered in the product’s container, affecting 2592 cartons.
Estradiol gel is under a...
10/08/2026
Pharmacy Learning Network
News
Zoladex (Goserelin) Implant Recalled Due to Improper Temperature Regulation
10/08/2026
Rebecca Amrick
A voluntary Class II recall has been issued for Zoladex (goserelin) implant due to issues in temperature regulation, a discrepancy that affects 296 cartons.
A voluntary Class II recall has been issued for Zoladex (goserelin) implant due to issues in temperature regulation, a discrepancy that affects 296 cartons.
A voluntary Class II recall has...
10/08/2026
Pharmacy Learning Network
News
Ranolazine Tablets Recalled Due to Failed Dissolution Specifications
10/08/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for ranolazine extended-release tablets after the product failed to meet dissolution specifications.
The US Food and Drug Administration (FDA) has issued a Class II recall for ranolazine extended-release tablets after the product failed to meet dissolution specifications.
The US Food and Drug...
10/08/2026
Pharmacy Learning Network
PharmLaw
AIDS Healthcare Foundation Settles Medicare Advantage False Claims Allegations
10/07/2026
Grace Taylor, MS, MA
The AIDS Healthcare Foundation has agreed to pay $1.44 million to resolve federal allegations involving unsupported diagnosis codes and Medicare Advantage payments.
The AIDS Healthcare Foundation has agreed to pay $1.44 million to resolve federal allegations involving unsupported diagnosis codes and Medicare Advantage payments.
The AIDS Healthcare Foundation...
10/07/2026
Pharmacy Learning Network
News
Olanzapine Tablets Recalled Due to Failed Impurities Specifications
10/01/2026
Rebecca Amrick
Olanzapine tablets are under a voluntary Class III recall after the product failed to meet impurities specifications, affecting 22 032 bottles.
Olanzapine tablets are under a voluntary Class III recall after the product failed to meet impurities specifications, affecting 22 032 bottles.
Olanzapine tablets are under a...
10/01/2026
Pharmacy Learning Network
News
Menow Sunscreen Pressed Powder Recalled Due to CGMP Deviations
10/01/2026
Rebecca Amrick
A voluntary Class II recall has been issued for Menow sunscreen pressed powder due to Current Good Manufacturing Practice (CGMP) deviations, a discrepancy that affects 2970 units.
A voluntary Class II recall has been issued for Menow sunscreen pressed powder due to Current Good Manufacturing Practice (CGMP) deviations, a discrepancy that affects 2970 units.
A voluntary Class II recall has...
10/01/2026
Pharmacy Learning Network

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
More Evidence of Cardiovascular Harm With NSAIDs
04/13/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In light of a new study, Dr Jennings advocates for practicing pharmacists to discuss the potential cardiovascular harm associated with short-term use of nonsteroidal anti-inflammatory drugs.
In light of a new study, Dr Jennings advocates for practicing pharmacists to discuss the potential cardiovascular harm associated with short-term use of nonsteroidal anti-inflammatory drugs.
In light of a new study, Dr...
04/13/2023
Pharmacy Learning Network
Commentary
Check Twice, Jab Once: How to Make Sure You Are Administering the Correct Vaccine
03/06/2023
Tyler Nichols, PharmD, BCPS
In this commentary, Tyler Nichols, PharmD, discusses common causes of vaccine errors and shares strategies for reducing risk, including storage best practices, technological solutions, and more.
In this commentary, Tyler Nichols, PharmD, discusses common causes of vaccine errors and shares strategies for reducing risk, including storage best practices, technological solutions, and more.
In this commentary, Tyler...
03/06/2023
Pharmacy Learning Network
Stock image of an open pill bottle with medication spilling out in a pharmacy.
Commentary
Drug Diversion and Leadership Response: Tips for Supporting Staff, Patients
02/01/2023
Sadik Owolewa, PharmD
In this commentary, Sadik Owolewa, PharmD, shares 5 strategies for preventing drug diversion with an emphasis on supporting health care workers, promoting a safe environment, and educating patients.
In this commentary, Sadik Owolewa, PharmD, shares 5 strategies for preventing drug diversion with an emphasis on supporting health care workers, promoting a safe environment, and educating patients.
In this commentary, Sadik...
02/01/2023
Pharmacy Learning Network
Stock image of eye and ear drops.
Commentary
An Eye (Drop) for an Eye, and an Ear (Drop) for an Ear
12/22/2022
Tyler Nichols, PharmD, BCPS
Tyler Nichols, PharmD, BCPS, international safe medication management fellow, Institute for Safe Medication Practices, reviews an incident where ear drops were administered in a patient's eye mistakenly and advises what steps may be taken to...
Tyler Nichols, PharmD, BCPS, international safe medication management fellow, Institute for Safe Medication Practices, reviews an incident where ear drops were administered in a patient's eye mistakenly and advises what steps may be taken to...
Tyler Nichols, PharmD, BCPS,...
12/22/2022
Pharmacy Learning Network
Stock image of a pharmacist holding a prescription and bottle of medication
Commentary
Conflict Management: I Don't Remember Learning This in Pharmacy School
12/14/2022
Jose Nery, PharmD
Jose Nery, PharmD, a 2022-2023 safe medication management fellow with ISMP, shares guidance for pharmacists hoping to better navigate conflict with prescribers while addressing concerns over the safety of an order.
Jose Nery, PharmD, a 2022-2023 safe medication management fellow with ISMP, shares guidance for pharmacists hoping to better navigate conflict with prescribers while addressing concerns over the safety of an order.
Jose Nery, PharmD, a 2022-2023...
12/14/2022
Pharmacy Learning Network
Headshot of Reetu Mukherji, MD, Georgetown University
Interview
Evaluating a Digital Tool for Monitoring Drug Toxicities in Patients With Colorectal Cancer
12/12/2022
Maria Asimopoulos
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD,...
12/12/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Still Seeking Answers for Safe Anticoagulation in Patients on Hemodialysis
12/08/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews a study comparing apixaban to warfarin in patients with atrial fibrillation who received hemodialysis for end-stage kidney disease.
Dr Jennings reviews a study comparing apixaban to warfarin in patients with atrial fibrillation who received hemodialysis for end-stage kidney disease.
Dr Jennings reviews a study...
12/08/2022
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
A Series on Medication Safety in the United States: Underutilization of Pharmacists
07/13/2022
Mark A. Munger, PharmD, FCCP, FACC, FHFSA
In the final installment of this series, Dr Munger discusses why pharmacists are uniquely equipped to employ strategies that improve medication safety.  
In the final installment of this series, Dr Munger discusses why pharmacists are uniquely equipped to employ strategies that improve medication safety.  
In the final installment of this...
07/13/2022
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
A Series on Medication Safety in the United States: Effective Strategies to Enhance Safety
07/06/2022
Mark A. Munger, PharmD, FCCP, FACC, FHFSA
In the second installment of this series, Dr Munger shares strategies for providers and health systems to improve medication safety.
In the second installment of this series, Dr Munger shares strategies for providers and health systems to improve medication safety.
In the second installment of...
07/06/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Is Hydroxychloroquine Harmful for the Heart?
06/30/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In the latest installment of Talking Therapeutics, Dr Jennings discusses possible adverse events associated with hydroxychloroquine.
In the latest installment of Talking Therapeutics, Dr Jennings discusses possible adverse events associated with hydroxychloroquine.
In the latest installment of...
06/30/2022
Pharmacy Learning Network

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use